Procter & Gamble [PG] vs Colgate-Palmolive [CL] Detailed Stock Comparison
Procter & Gamble
NYSE
Loading...
Colgate-Palmolive
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Procter & Gamble wins in 11 metrics, Colgate-Palmolive wins in 9 metrics, with 0 ties. Procter & Gamble appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Procter & Gamble | Colgate-Palmolive | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.25 | 23.39 | Colgate-Palmolive |
| Price-to-Book Ratio | 7.22 | 95.83 | Procter & Gamble |
| Debt-to-Equity Ratio | 69.86 | 832.51 | Procter & Gamble |
| PEG Ratio | 21.28 | 21.58 | Procter & Gamble |
| EV/EBITDA | 16.27 | 15.55 | Colgate-Palmolive |
| Profit Margin (TTM) | 18.95% | 14.54% | Procter & Gamble |
| Operating Margin (TTM) | 25.15% | 20.86% | Procter & Gamble |
| EBITDA Margin (TTM) | 25.15% | 20.86% | Procter & Gamble |
| Return on Equity | 31.24% | 398.04% | Colgate-Palmolive |
| Return on Assets (TTM) | 10.91% | 15.56% | Colgate-Palmolive |
| Free Cash Flow (TTM) | $14.04B | $3.55B | Procter & Gamble |
| Dividend Yield | 1.92% | 2.29% | Colgate-Palmolive |
| 1-Year Return | -9.29% | -21.23% | Procter & Gamble |
| Price-to-Sales Ratio (TTM) | 4.38 | 3.37 | Colgate-Palmolive |
| Enterprise Value | $397.88B | $75.00B | Procter & Gamble |
| EV/Revenue Ratio | 4.72 | 3.75 | Colgate-Palmolive |
| Gross Profit Margin (TTM) | 49.11% | 60.06% | Colgate-Palmolive |
| Revenue per Share (TTM) | $36 | $25 | Procter & Gamble |
| Earnings per Share (Diluted) | $6.51 | $3.56 | Procter & Gamble |
| Beta (Stock Volatility) | 0.36 | 0.35 | Colgate-Palmolive |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Procter & Gamble vs Colgate-Palmolive Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Procter & Gamble | -0.46% | -1.32% | 1.81% | -3.24% | -6.22% | -4.87% |
| Colgate-Palmolive | -0.93% | -2.17% | -1.99% | -10.59% | -8.30% | -8.03% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Procter & Gamble | -9.29% | 14.19% | 14.95% | 125.76% | 158.98% | 182.22% |
| Colgate-Palmolive | -21.23% | 10.03% | 9.82% | 32.84% | 115.25% | 210.63% |
News Based Sentiment: Procter & Gamble vs Colgate-Palmolive
Procter & Gamble
News based Sentiment: NEUTRAL
September presented a mixed bag for P&G, with positive analyst ratings and product launches offset by some insider selling and diverging institutional investment activity. While the company is proactively addressing cost pressures and innovating, the slower global market growth and economic uncertainty create a cautious outlook.
Colgate-Palmolive
News based Sentiment: MIXED
September presented a mixed bag for Colgate-Palmolive, with a declining stock price and cautious growth outlook countered by a new productivity program and continued dividend payments. While the long-term strategy remains intact, near-term challenges and mixed analyst sentiment create a complex investment picture.
Performance & Financial Health Analysis: Procter & Gamble vs Colgate-Palmolive
| Metric | PG | CL |
|---|---|---|
| Market Information | ||
| Market Cap | $369.86B | $67.31B |
| Market Cap Category | Mega cap | Large cap |
| 10 Day Avg. Volume | 6,185,910 | 4,513,740 |
| 90 Day Avg. Volume | 6,529,780 | 4,797,703 |
| Last Close | $157.90 | $83.28 |
| 52 Week Range | $149.91 - $180.43 | $82.29 - $106.44 |
| % from 52W High | -12.49% | -21.76% |
| All-Time High | $180.43 (Nov 25, 2024) | $109.30 (Sep 02, 2024) |
| % from All-Time High | -12.49% | -23.81% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.02% | 0.01% |
| Quarterly Earnings Growth | 0.15% | 0.02% |
| Financial Health | ||
| Profit Margin (TTM) | 0.19% | 0.15% |
| Operating Margin (TTM) | 0.25% | 0.21% |
| Return on Equity (TTM) | 0.31% | 3.98% |
| Debt to Equity (MRQ) | 69.86 | 832.51 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $21.88 | $0.87 |
| Cash per Share (MRQ) | $4.08 | $1.75 |
| Operating Cash Flow (TTM) | $17.82B | $3.92B |
| Levered Free Cash Flow (TTM) | $11.38B | $2.73B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.92% | 2.29% |
| Last 12-Month Dividend | $3.03 | $2.02 |
Valuation & Enterprise Metrics Analysis: Procter & Gamble vs Colgate-Palmolive
| Metric | PG | CL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.25 | 23.39 |
| Forward P/E | 21.28 | 21.58 |
| PEG Ratio | 21.28 | 21.58 |
| Price to Sales (TTM) | 4.38 | 3.37 |
| Price to Book (MRQ) | 7.22 | 95.83 |
| Market Capitalization | ||
| Market Capitalization | $369.86B | $67.31B |
| Enterprise Value | $397.88B | $75.00B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.72 | 3.75 |
| Enterprise to EBITDA | 16.27 | 15.55 |
| Risk & Other Metrics | ||
| Beta | 0.36 | 0.35 |
| Book Value per Share (MRQ) | $21.88 | $0.87 |
Financial Statements Comparison: Procter & Gamble vs Colgate-Palmolive
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PG | CL |
|---|---|---|
| Revenue/Sales | $20.89B | $4.91B |
| Cost of Goods Sold | $10.63B | $1.92B |
| Gross Profit | $10.26B | $2.99B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $4.35B | $1.08B |
| EBITDA | $5.46B | $1.17B |
| Pre-Tax Income | $4.52B | $953.00M |
| Income Tax | $895.00M | $227.00M |
| Net Income (Profit) | $3.63B | $726.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PG | CL |
|---|---|---|
| Cash & Equivalents | $9.56B | $1.11B |
| Total Current Assets | $25.39B | $5.81B |
| Total Current Liabilities | $36.06B | $6.86B |
| Long-Term Debt | $25.70B | $6.57B |
| Total Shareholders Equity | $52.28B | $733.00M |
| Retained Earnings | $129.97B | $26.41B |
| Property, Plant & Equipment | $0 | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PG | CL |
|---|---|---|
| Operating Cash Flow | $3.71B | $657.00M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $2.85B | $476.00M |
| Debt Repayment | $-1.05B | $-4.00M |
| Common Stock Repurchase | $-1.35B | $-284.00M |
Short Interest & Institutional Ownership Analysis
| Metric | PG | CL |
|---|---|---|
| Shares Short | 17.25M | 11.61M |
| Short Ratio | 2.42 | 2.30 |
| Short % of Float | 0.01% | 0.02% |
| Average Daily Volume (10 Day) | 6,185,910 | 4,513,740 |
| Average Daily Volume (90 Day) | 6,529,780 | 4,797,703 |
| Shares Outstanding | 2.34B | 812.57M |
| Float Shares | 2.34B | 757.87M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 0.70% | 0.86% |
Dividend Analysis & Yield Comparison: Procter & Gamble vs Colgate-Palmolive
| Metric | PG | CL |
|---|---|---|
| Last 12-Month Dividend | $3.03 | $2.02 |
| Last 12-Month Dividend Yield | 1.92% | 2.29% |
| 3-Year Avg Annual Dividend | $3.51 | $1.95 |
| 3-Year Avg Dividend Yield | 0.63% | 0.59% |
| 3-Year Total Dividends | $10.53 | $5.85 |
| Ex-Dividend Date | Jan 24, 2025 | Apr 17, 2025 |